Voice Telerehabilitation

Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Other)
Overall Status
Completed
CT.gov ID
NCT05747859
Collaborator
(none)
15
1
2.3
6.4

Study Details

Study Description

Brief Summary

The aim of the study was to determine functional results of telerehabilitation (TR) in subjects affected by iatrogenic unilateral vocal fold paralysis (UVFP) during the COVID-19 pandemic outbreak. 40 patients with iatrogenic unilateral vocal fold paralysis underwent voice teletherapy with a synchronous approach. A multidimensional assessment by means of videolaryngostroboscopy, acoustic and perceptual analysis and patient self-assessment was carried out before, at the end of teletherapy and six months later.

Condition or Disease Intervention/Treatment Phase
  • Other: teletherapy

Study Design

Study Type:
Observational
Actual Enrollment :
15 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Voice Telerehabilitation for Patients Affected by Iatrogenic Unilateral Vocal Fold Paralysis: From Necessity to Opportunity in the COVID-19 Time
Actual Study Start Date :
Nov 5, 2021
Actual Primary Completion Date :
Dec 30, 2021
Actual Study Completion Date :
Jan 15, 2022

Outcome Measures

Primary Outcome Measures

  1. analysis [1 month]

    to analyze the functional outcomes achieved by a group of patients with recent onset of iatrogenic UVFP who were referred to TR using a synchronous approach.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria:age between 18-75 years, onset of UVFP less than 1 month before, internet access, availability and ability to use a computer with an internal or external webcam.

  • Exclusion Criteria:previous history of laryngeal pulmonary or gastric surgery, current or previous pulmonary diseases, hearing loss, neurological or motor deficits, reading difficulties, dysphagia, unavailability of a computer and a webcam.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fondazione Policlinico Universitario A. Gemelli Roma Italy 00168

Sponsors and Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Investigators

  • Principal Investigator: Giorgia Mari, SLP MSC, Fondazione Policlinico Universitario A. Gemelli, Rome

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
mari Giorgia, Principal Investigator, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ClinicalTrials.gov Identifier:
NCT05747859
Other Study ID Numbers:
  • 4427
First Posted:
Feb 28, 2023
Last Update Posted:
Feb 28, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 28, 2023